Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials [version 2; peer review: 2 approved]
Background: Opioids prescribed for the management of chronic noncancer pain are associated with nausea, vomiting, and constipation. Methylnaltrexone, a peripherally acting µ-opioid receptor antagonist, has demonstrated robust efficacy and was well-tolerated in treating opioid-induced constipation wi...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
F1000 Research Ltd
2023-07-01
|
| Серии: | F1000Research |
| Предметы: | |
| Online-ссылка: | https://f1000research.com/articles/10-891/v2 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|